1. health and fitness
2. disease
3. cancer

CHICAGO UROLOGICAL SOCIETY
In Conjunction with the Chicago Medical Society
PROSTATE CANCER
KEYNOTE ADDRESS: INDERBIR S. GILL, MD, MCh
University of Southern California
Wednesday, November 5th at 1:30 p.m.
The University Club of Chicago
Target Audience: Urologists
EDU CA T I ON A L NE E DS
F ACU LTY LIS T
Prostate cancer is the most common solid organ
malignancy affecting the male population in the
US with 223,000 new cases expected in 2014. Every
urologist diagnoses and treats prostate cancer. In the
past decade, many advances occurred in the field of
prostate cancer. This program will highlight many of
these changes ensuring that the urologic community
keeps up to date with the care of men with prostate
cancer.
Michael R. Abern, MD
Assistant Professor of Urology
University of Illinois at Chicago Department of Urology- Chicago, IL
Dr. Abern has disclosed that he has no relevant financial
relationships with any commercial interests.
Leslie A. Deane, MB.BS, FRCSC
Associate Professor of Urology
Rush University- Chicago, IL
Dr. Deane has disclosed that he has no relevant financial
relationships with any commercial interests.
Inderbir S. Gill, MD, MCh
Chairman and Professor, Deptarment of Urology
Founding Executive Director, USC Institute of Urology
University of Southern California, Keck School of Medicine
Los Angeles, CA
Dr. Gill has disclosed that he is a consultant for Mimic Technologies
and EDAP TMS, and has stock options with Hansen Medical.
Ari Goldberg, MD, PhD
Director of Body Imaging and MRI
Loyola University Medical Center- Maywood, IL
Dr. Goldberg has disclosed that he has no relevant financial
relationships with any commercial interests.
Alex Gorbonos, MD, FACS
Assistant Professor of Urology
Loyola University Medica Center- Maywood, IL
Dr. Gorbonos has disclosed that he has no relevant financial
relationships with any commercial interests.
ED U C A T I ONA L O B J E C T I VE S
At the conclusion of this meeting, the attendee should be able
to:
1. Differentiate the role of MRI in diagnosing prostate cancer in men with previously negative biopsies and persistently
high suspicion of disease presence.
2. Assess the new genetic tests that help risk stratify prostate cancer.
3. Identify the appropriate candidates for active surveillance and review the current follow up protocol.
4. Compare the current data on IMRT and proton therapy for prostate cancer.
5. Extrapolate the differences in surgical and radiation
approaches to high-risk prostate cancer patients.
6. Relate the results of CHAARTED trial on the role of early chemotherapy in castrate-sensitive prostate cancer.
7. Analyze the concept of focal therapy for prostate cancer and reflect on the concerns and questions which need to be debated and addressed.
8. Consider the incorporation of real-time imaging and guided-biopsies into the diagnostic and treatment armamentarium for prostate cancer.
Gopal N. Gupta, MD
Assistant Professor, Department of Urology and Surgery
Loyola University Stritch School of Medicine- Maywood, IL
Dr. Gupta has disclosed that he has no relevant financial
relationships with any commercial interests.
Matthew H. Harkenrider, MD
Assistant Progessor, Department of Radiation Oncology
Loyola University Department of Radiation Oncology- Maywood, IL
Dr. Harkenrider has disclosed that he has no relevant financial
relationships with any commercial interests.
Brian Helfand, MD
Assistant Professor, Department of Surgery
Northwestern University- Chicago, IL
Dr. Helfand has disclosed that he is a speaker for Genomic Health.
Elizabeth Henry, MD
Assistant Professor
Loyola University Cardinal Bernardin Cancer Cener- Maywood, IL
Dr. Henry has disclosed that she has no relevant financial
relationships with any commercial interests.
PROGRA M S C HE DUL E
Wednesday, November 5, 2014
Program Chairman: Alex Gorbonos, MD, FACS
1:30 - 1:55 p.m.
Role of MRI in Prostate Cancer Detection and Treatment
Ari Goldberg, MD
1:55 - 2:20 p.m.
Image-guided Biopsy Techniques in Prostate Cancer
Gopal Gupta, MD
2:20 - 2:45 p.m.
Genetic Testing in Prostate Cancer
Brian Helfand, MD
2:45 - 3:10 p.m.
Active Surveillance Approach to Prostate Cancer
Leslie Deane, MBBS
3:10 - 3:20 p.m.
Comments/Discussion: Brian Helfand, MD
3:20 - 3:35 p.m.
Break
3:35 - 4:00 p.m.
Update on Radiotherapy for Prostate Cancer
Matthew Harkenrider, MD
4:00 - 4:25 p.m.
Approach to High-Risk Prostate Cancer Patient
Michael Abern, MD, BS
4:25 - 4:50 p.m.
Sequence of Treatment in Metastatic Prostate Cancer
Elizabeth Henry, MD
4:50 - 5:15 p.m.
Prostate Cancer Cases
Alex Gorbonos, MD, FACS
5:15 - 6:15 p.m.
Fellowship Hour
6:15 - 7:15 p.m.
Dinner
7:15 – 8:00 p.m.
Keynote Address: Image-guided Biopsies & Focal
Therapy for Prostate Cancer: Work-in-Progress
Inderbir S. Gill, MD, MCh
CM E IN F OR M A T I O N
This activity has been planned and implemented in accordance with the accreditation requirements
and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint
providership of the Chicago Medical Society and the Chicago Urological Society. The Chicago Medical
Society is accredited by the ACCME to provide continuing medical education for physicians.
The Chicago Medical Society designates this live activity for a maximum of 4.25 AMA PRA Category 1
Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation
in the activity.
U N I V ERSIT Y C L U B
Located at:
76 E. Monroe
Chicago, IL 60603
Parking:
Valet parking is available with the doorman
at standard rates of $20 per vehicle.
Self parking is available at the following
garages:
-Grant Park East Garage
-located at Colombus/Michigan
-Grant Park North Garage
-located at Madison/Michigan
-Grant Park South Garage
-located at Jackson/Michigan
-Inter Parking
-located at 55 E. Monroe
*Please note University Club dresscode is
business casual to business attire.
EXH I BI T OR S
CME P LANNING CO MMITTEE
The following planning members of
the Chicago Medical Society’s CME
Subcommittee on Joint Providorship have
disclosed that they do not have any relevant
financial relationships with commercial
interests:
Ajay K. Chauhan, MD, Chairman, Howard
Axe, MD, Vickie L. Becker, MD, Adrienne L.
Fregia, MD, Robert W. Panton, MD, Loren
S. Schechter, MD, Kathy M. Tynus, MD and
Cecilia Merino, Director of Education.
The following planning members of the
Chicago Urological Society have disclosed
that they do not have any relevant financial
relationships with any commercial interests:
Alex Gorbonos, MD, Course Director,
and Jessica Reynertson, Administrative
Coordinator.
REGISTRATION INFORMATION
Abbvie
Activas
Allergan
American Medical Systems
Astellas Oncology
Auxulium Pharmacetuicals
Coloplast
Cook Medical
Dendreon
Endo Pharmaceuticals
Ferring
Janssen Biotech, Inc.
Lumenis
Medivation
NeoTract, Inc.
Olympus
Pfizer
Xodus Medical
*as of 09/29/2014
This CME activity did not receive
any educational support.
Online at www.cuschicago.com
Call the CUS Office: 312-853-2053
Email: info@cuschicago.com